C12Y 402/02
Acting on polysaccharides
Official title: acting on polysaccharides (4.2.2)
C12Y402/02 (Acting on polysaccharides) appears on 144 US grants and 262 published applications in this corpus.
Search patents in C12Y- Granted patents
- 144
- Published applications
- 262
- Assignees
- 138
- Inventors
- 512
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 5 |
| 2003 | 2 | 3 |
| 2004 | 1 | 3 |
| 2005 | 1 | 4 |
| 2006 | 3 | 7 |
| 2007 | 0 | 5 |
| 2008 | 3 | 3 |
| 2009 | 5 | 10 |
| 2010 | 4 | 8 |
| 2011 | 5 | 7 |
| 2012 | 4 | 6 |
| 2013 | 4 | 8 |
| 2014 | 7 | 10 |
| 2015 | 7 | 16 |
| 2016 | 7 | 9 |
| 2017 | 12 | 20 |
| 2018 | 9 | 15 |
| 2019 | 10 | 23 |
| 2020 | 14 | 10 |
| 2021 | 8 | 12 |
| 2022 | 4 | 14 |
| 2023 | 4 | 17 |
| 2024 | 4 | 21 |
| 2025 | 6 | 15 |
| 2026 | 7 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 402/02004Chondroitin abc lyase , i.e. chondroitinase47
- C12Y 402/02002Pectate lyase24
- C12Y 402/0202Chondroitin-sulfate-abc endolyase21
- C12Y 402/02001Hyaluronate lyase19
- C12Y 402/02005Chondroitin ac lyase18
- C12Y 402/02019Chondroitin b lyase15
- C12Y 402/02021Chondroitin-sulfate-abc exolyase13
- C12Y 402/0201Pectin lyase12
All 25 subgroupsShow fewer
- C12Y 402/02003Poly lyase8
- C12Y 402/02012Xanthan lyase7
- C12Y 402/02007Heparin lyase , i.e. heparinase i6
- C12Y 402/02008Heparin-sulfate lyase5
- C12Y 402/02014Glucuronan lyase2
- C12Y 402/02018Inulin fructotransferase2
- C12Y 402/02011Poly lyase , i.e. alginase ii1
- C12Y 402/02015Anhydrosialidase1
- C12Y 402/02017Inulin fructotransferase1
- C12Y 402/02023Rhamnogalacturonan endolyase1
- C12Y 402/02006Oligogalacturonide lyase0
- C12Y 402/02009Pectate disaccharide-lyase0
- C12Y 402/02013Exo--alpha-d-glucan lyase0
- C12Y 402/02016Levan fructotransferase0
- C12Y 402/02022Pectate trisaccharide-lyase0
- C12Y 402/02024Rhamnogalacturonan exolyase0
- C12Y 402/02025Gellan lyase0
Recent patents
- Targeted chondroitinase ABC fusion proteins and complexes thereof7 Jul 2026US 12,674,155 B2University of Florida Research Foundation, Inc.
- Modified bacterial hyaluronidase polypeptide, production process, pharmaceutical compositions and their uses23 Jun 2026US 12,662,664 B2Pharmact Holding AG
- Application of microbial glycosidase as an anti-viral therapeutic, prognostic, and diagnostic26 May 2026US 12,636,353 B2The Regents of the University of California
- Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes19 May 2026US 12,630,484 B2Spogen Biotech Inc.
- Hyaluronidase variants with improved stability and pharmaceutical composition comprising the same5 May 2026US 12,618,055 B2Alteogen, Inc.
- Medium composition for improving pectinase productivity of bacillus spp. and method for producing pectinase by using same8 Oct 2026US 2026/0308563 A1Cj Cheiljedang Corporation
- Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes30 Jul 2026US 2026/0217621 A1Spogen Biotech Inc.
- Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes30 Jul 2026US 2026/0217622 A1Spogen Biotech Inc.
- Novel hyaluronidase variants with improved stability and pharmaceutical composition comprising the same9 Jul 2026US 2026/0193632 A1Alteogen, Inc.
- Novel hyaluronidase variants with improved stability and pharmaceutical composition comprising the same9 Jul 2026US 2026/0193633 A1Alteogen, Inc.
Most cited
By later US patents
- Methods of repairing connective tissues151US 5,916,557 AInternational Technology Management Associates, Ltd. · 1999
- Methods and materials for degrading xanthan88US 6,110,875 ABJ Services Company · 2000
- Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof40US 6,569,661 B1Biomarin Pharmaceutical Inc. · 2003
- Methods for treating diseases caused by deficiencies of recombinant alpha-L-iduronidase38US 6,858,206 B22005
- Use of glycosaminoglycans degrading enzymes for management of airway associated diseases37US 6,153,187 AInsight Strategy & Marketing Ltd. · 2000